Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 07/31/14
Due: 07/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer | NCT00557492 | Amer Zureikat | user2@example.com | None | 2006-12-31 | 2016-12-31 | 2017-12-31 | - | - | 2025-07-14 |
| Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas | NCT01128296 | Amer Zureikat | user2@example.com | None | 2010-10-31 | 2014-07-31 | 2015-07-31 | - | - | 2025-07-14 |